Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016;12(2):117-20.
doi: 10.2174/1573403X12666151119165438.

Pharmacologic Approach to Heart Failure in Children

Affiliations
Review

Pharmacologic Approach to Heart Failure in Children

Sebastian C Tume et al. Curr Cardiol Rev. 2016.

Abstract

Heart failure may result from a wide variety of causes and present with varying degrees of severity. In large part patients present with varying degrees of congestion and compromised cardiac output. In this review a pathophysiologic construct is provided to guide the pharmacologic management of acute heart failure that leads to decreased congestion and improved cardiac output. Pharmacologic therapies that are used to treat chronic heart failure are also highlighted and provide the framework for transitioning from acute to preventative pharmacologic strategies.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Bronicki R.A., Anas N.G. Cardiopulmonary interaction. Pediatr. Crit. Care Med. 2009;10(3):313–322. doi: 10.1097/PCC.0b013e31819887f0. - DOI - PubMed
    1. Artman M., Graham T.P., Jr Guidelines for vasodilator therapy of congestive heart failure in infants and children. Am. Heart J. 1987;113(4):994–1005. doi: 10.1016/0002-8703(87)90062-7. - DOI - PubMed
    1. Mason D.T. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure. Am. J. Med. 1978;65(1):106–125. doi: 10.1016/0002-9343(78)90700-3. - DOI - PubMed
    1. Schwinn D.A. Adrenoceptors as models for G protein-coupled receptors: structure, function and regulation. Br. J. Anaesth. 1993;71(1):77–85. doi: 10.1093/bja/71.1.77. - DOI - PubMed
    1. Bellomo R., Chapman M., Finfer S., Hickling K., Myburgh J., Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Lancet. 2000;356(9248):2139–2143. doi: 10.1016/S0140-6736(00)03495-4. - DOI - PubMed